gene patents gene patents
Stories About

gene patents

According to the law in most states, health care providers own patients' medical records. But federal privacy law governs how that information can be used. And whether or not you can profit from your own medical data is murky. alicemoi/Getty Images/RooM RF hide caption

toggle caption
alicemoi/Getty Images/RooM RF

If Your Medical Information Becomes A Moneymaker, Could You Get A Cut?

  • Download
  • <iframe src="https://www.npr.org/player/embed/657493767/657588654" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Smallpox virus, colorized and magnified in this micrograph 42,000 times, is the real concern for biologists working on a cousin virus — horsepox. They're hoping to develop a better vaccine against smallpox, should that human scourge ever be used as a bioweapon. Chris Bjornberg/Science Source hide caption

toggle caption
Chris Bjornberg/Science Source

Did Pox Virus Research Put Potential Profits Ahead of Public Safety?

  • Download
  • <iframe src="https://www.npr.org/player/embed/585385308/586759980" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Biotechnologist Feng Zhang of the Broad Institute (a joint venture of MIT and Harvard University) was awarded a patent for CRISPR gene-editing technology in 2014. But two other scientists — Jennifer Doudna, of the University of California, Berkeley, and Emmanuelle Charpentier, then of the University of Vienna — published their description of the underlying biology first. Susan Walsh/AP hide caption

toggle caption
Susan Walsh/AP

Broad Institute Wins Big Battle Over CRISPR Gene-Editing Patent

  • Download
  • <iframe src="https://www.npr.org/player/embed/515459773/515529417" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Emmanuelle Charpentier (left) and Jennifer Doudna have a case for being the inventors of CRISPR-cas9, a transformative tool for gene editing. Miguel Riopa/AFP/Getty Images hide caption

toggle caption
Miguel Riopa/AFP/Getty Images

Scientists Battle In Court Over Lucrative Patents For Gene-Editing Tool

  • Download
  • <iframe src="https://www.npr.org/player/embed/504454201/504467257" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Medical geneticist Dr. Harry Ostrer (center) talks to the press outside the U.S. Supreme Court on Monday. The court heard oral arguments on the highly charged question of whether human genes can be patented. Mladen Antonov/AFP/Getty Images hide caption

toggle caption
Mladen Antonov/AFP/Getty Images